Pay in 4 interest-free payments of $6.25 Learn more
Ships within 48 hours · Estimated delivery Sep 27 - Oct 2
Although this medication was originally designed for type 2 diabetes and weight management, its classification as a GLP-1 agonist has sparked discussions about potential off-label benefits, particularly in the realm of neurodevelopmental disorders like ADHD
A Research Overview Tirzepatide is a synthetic 39-amino-acid peptide that acts as a dual agonist at both the glucose-dependent insulinotropic polypeptide (GIP) receptor and the glucagon-like peptide-1 (GLP-1) receptor
These typically resolve within days to weeks
Fascinatingly, it mimicked glucagon-like peptide-1, known famously today as a GLP-1: a hormone the human pancreas uses to stimulate insulin release after meals
US$ 27.61
US$ 20.20
US$ 28.25
US$ 27.62
US$ 21.63
US$ 21.81
US$ 23.34
